Surevest’s ICU Medical ICUI Stock Holding History

Surevest’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$0	Hold	2	–	–	﹤0.01%	545
2022 Q2	$0	Hold	2	–	–	﹤0.01%	573
2022 Q1	$0	Hold	2	–	–	﹤0.01%	539
2021 Q4	$0	Buy	+2	New	+$467	﹤0.01%	534

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Surevest's ICUI Position: Q3 2022 in Review

Surevest held its ICU Medical (ICUI) position steady in Q3 2022 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #545.

Surevest first reported a position in ICUI in Q4 2021 and has held it in 4 quarters since. 243 funds tracked by Wall St. Rank hold ICUI as of Q3 2022.

Surevest held 2 shares of ICU Medical worth $0 as of Q3 2022.
Surevest left its ICU Medical share count unchanged in Q3 2022.
ICU Medical made up ﹤0.01% of Surevest's portfolio in Q3 2022, its #545 holding.
Surevest first reported a position in ICU Medical in Q4 2021 and has held it in 4 quarters since.
243 funds tracked by Wall St. Rank held ICU Medical as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.